ResearcherUniversitätsmedizin GöttingenNo recent work listed

Katharina M. Ewers

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5043951619. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/cancers13246163 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xin Wang · 1 shared paper, 2021 · strength 0.13
- Paper HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. DOI 10.3390/cancers13246163 ↗
Shilpa Patil · 1 shared paper, 2021 · strength 0.13
- Paper HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. DOI 10.3390/cancers13246163 ↗
Elisabeth Heßmann · 1 shared paper, 2021 · strength 0.13
- Paper HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. DOI 10.3390/cancers13246163 ↗
Matthias Dobbelstein · 1 shared paper, 2021 · strength 0.13
- Paper HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. DOI 10.3390/cancers13246163 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.